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Convergence of innate and Adaptive 
immunity during Human Aging
Branca I. Pereira and Arne N. Akbar*
Division of Infection and Immunity, University College London, London, UK
Aging is associated with profound changes in the human immune system, a 
phenomenon referred to as immunosenescence. This complex immune remodeling 
affects the adaptive immune system and the CD8+ T cell compartment in particular, 
leading to the accumulation of terminally differentiated T cells, which can rapidly 
exert their effector functions at the expenses of a limited proliferative potential. In this 
review, we will discuss evidence suggesting that senescent αβCD8+ T cells acquire 
the hallmarks of innate-like T cells and use recently acquired NK cell receptors as an 
alternative mechanism to mediate rapid effector functions. These cells concomitantly 
lose expression of co-stimulatory receptors and exhibit decreased T cell receptor 
signaling, suggesting a functional shift away from antigen-specific activation. The 
convergence of innate and adaptive features in senescent T cells challenges the 
classic division between innate and adaptive immune systems. Innate-like T cells are 
particularly important for stress and tumor surveillance, and we propose a new role 
for these cells in aging, where the acquisition of innate-like functions may represent a 
beneficial adaptation to an increased burden of malignancy with age, although it may 
also pose a higher risk of autoimmune disorders.
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iNTRODUCTiON
Natural killer cells and αβCD8+ T lymphocytes are the two major cell lineages with constitutive 
cytotoxic activity and have a crucial role in the recognition and killing of abnormal cells. However, 
the paradigm for the recognition of target cells is fundamentally different between these two cell 
types: conventional αβCD8+ T cells rely on the T cell receptor (TCR) to recognize specific peptides 
presented by major histocompatibility complex class-I (MHC-I) molecules, whereas NK cells use 
a repertoire of germ line-encoded receptors to detect “missing self ” or “altered-self ” antigens and 
directly kill abnormal cells, without prior sensitization (1). Besides antigen specificity, the devel-
opment of immunological memory is conventionally another distinctive feature between NK and 
T cells, categorizing them into distinct arms of the immune system and the innate and adaptive 
immune system, respectively (2).
Nevertheless, accumulating evidence supports the existence of NK cell memory (3, 4), as 
well as evidence for TCR-independent responses mediated by αβCD8+ T lymphocytes (5–7), 
suggesting that the conventional limits between the innate and adaptive arms of the immune 
system may be not as distinct as first thought (8). NK and T lymphocytes have a common origin 
from a lymphoid progenitor cell in the bone marrow (9), and recent comparative proteomic 
and transcriptomic studies have demonstrated a remarkably close proximity between effector 
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αβCD8+ T lymphocytes and NK cells (10, 11), reiterating an 
evolutionary ancestry and shared biology between the two cell 
lineages.
An increasing body of literature reveals the existence of subsets 
of T cells with features that bridge innate and adaptive immunity 
(12–14). In humans, these innate-like T cells comprise the invari-
ant natural killer T (iNKT) cells, CD1d-restricted natural killer 
T (NKT) cells, mucosa-associated invariant T (MAIT) cells, and 
γδT cells. These cells typically co-express a TCR and NK cell line-
age markers, distinguishing them from NK cells and other innate 
lymphoid cells (ILCs), which lack the expression of a TCR or 
somatically rearranged receptors. Functionally, innate-like T cells 
respond to TCR ligation but are also able to respond rapidly to 
danger signals and pro-inflammatory cytokines, independently 
of TCR stimulation, resembling innate cells. Recently, subsets of 
conventional αβCD8+ T cells expressing NK cell markers and 
intraepithelial T cells have been included in this vaguely defined 
group of innate-like T cells (15, 16). Despite the similarities in 
phenotype and function, there are clear differences in ontogeny 
and tissue distribution between them.
In this review, we will discuss recent evidence that aging is 
associated with the expansion of a subset of conventional αβCD8+ 
T cells with phenotypic, functional, and transcriptomic features 
that resemble NK cells. Such innate-like αβCD8+ T  cells have 
the characteristics of terminally differentiated T  cells, and the 
acquisition of functional NK receptors is most likely part of a 
general reprograming of the CD8+ T  cell compartment during 
human aging, to ensure broad and rapid effector functions. 
We  propose that innate-like αβCD8+ T  cells share important 
features with other innate-like T cells; however, fundamental 
differences in origin and development separate them from 
truly innate cells. Interestingly, these cells are also differentially 
affected by aging, suggesting distinct roles in immune responses 
at different times of life.
iMMUNOSeNeSCeNCe
Aging is associated with a general decline in immune function, 
contributing to a higher risk of infection, cancer, and autoim-
mune diseases in the elderly. Such faulty immune responses are 
the result of a profound remodeling of the immune system that 
occurs with age, generally termed as immunosenescence (17). 
While the number of naïve T cells emerging from the thymus 
progressively decreases with age as a result of thymic involution 
(18), the memory T cell pool expands and exhibits significant 
changes in the phenotype and function of antigen-experienced 
T cells, particularly evident in the CD8+ T cell compartment (19). 
Chronic immune activation due to persistent viral infections, 
such as cytomegalovirus (CMV) and Epstein–Barr virus (EBV), 
is one of the main drivers contributing to the accumulation 
of highly differentiated antigen-specific CD8+ T lymphocytes 
that have characteristics of replicative senescence (20, 21). 
In   combination with the depletion of the peripheral pool of 
naïve T cells, the accumulation of these terminally differentiated 
T cells with age skews the immune repertoire and has been 
implicated in the impaired immune responses to new antigens 
and vaccination in the elderly (22, 23).
The widespread effects of aging on the immune system have 
been reviewed elsewhere (24) and include defects in the function 
of natural killer cells, neutrophils, macrophages, and dendritic 
cells as well as B cells and hematopoietic stem cells. In the innate 
immune compartment, changes in the phenotype and function 
of NK cells have been described (25) and associated with the 
accumulation of CD56dim NK cells with a mature phenotype, 
characterized by the increased expression of maturation mark-
ers, such as CD57 (26) and KLRG1 (27, 28). Although the 
effects of aging on the cytolytic function of NK cells are still 
controversial, our group recently identified a subset of CD56dim 
KLRG1high NK cells that is expanded in the elderly, displaying 
impaired cytotoxicity and proliferation as well as other features 
of senescence (28).
While many aspects of the immune response are impaired, 
there is also evidence for hyperresponsiveness of the immune 
system during aging (29). It is likely that there is a complex 
remodeling of the immune system throughout life in an attempt 
to maintain effective immune responses, which could be benefi-
cial in the responses to infections and cancer but may carry an 
increased risk of autoimmune and inflammatory diseases in the 
elderly (30).
CHARACTeRiSTiCS OF HiGHLY 
DiFFeReNTiATeD αβCD8+ T CeLLS
Multiple phenotypic and functional features have been proposed 
to define senescent CD8+ T cells (Table 1). Loss of co-stimulatory 
receptors, such as CD28 and CD27, is one of the most consist-
ent immunological markers of T cell aging (31, 32) which, in 
combination with other markers of maturation such as CD45RA, 
KLRG1, and CD57 expression, identifies a subpopulation of 
long-lived immune cells with characteristics of terminal dif-
ferentiation or senescence (33).
Several lines of evidence indicate that end-stage CD27− 
CD28−CD45RA+ CD57+ T cells accumulate significantly in 
older humans (34), during chronic viral infections (35) and 
in chronic inflammatory diseases (36). These cells exhibit the 
characteristic features of senescence that include accumulation 
of DNA damage markers, short telomeres, low proliferation, 
and loss in the capacity to activate the enzyme telomerase 
(37–39). A paradoxical observation is that senescent CD8+ 
T cells maintain potent effector functions, despite the loss of 
proliferative capacity, and thus should not be considered as a 
residual population of dysfunctional cells. On the contrary, these 
cells are polyfunctional, reflecting their ability to simultaneously 
carry out multiple functions, including secretion of IFN-γ and 
TNF-α and cytotoxicity (35, 38, 40), and this is an important 
observation that distinguishes senescent from exhausted T cells 
(41). Nevertheless, the increased secretion of pro-inflammatory 
cytokines by senescent T cells may have detrimental effects on 
the tissue microenvironment and contribute to the age-associated 
low-grade inflammatory state termed “inflammaging” (42).
Highly differentiated T cells have impaired TCR signaling 
(43, 44). We recently described that senescent CD27-28− CD4+ 
T cells exhibit decreased expression of key components of the 
TCR signalosome, such as LCK, LAT, and SLP-76 (39), and found 
TAbLe 1 | Phenotypic and functional characteristics of senescent CD8+ 
T cells, compared to less differentiated subsets.
early  
differentiation
intermediate 
differentiation
Terminal 
differentiation
Phenotypic markers
CD28 ++ +/− –
CD27 ++ +/− –
CD45RA ++ +/− +/−
CCR7 ++ + –
CD62L ++ + –
CD57 – +/− ++
KLRG1 – +/− ++
Other NKR (KIR, 
NKG2, and CD56)
– +/− ++
Functional features
Proliferation ++ + –
Telomerase 
activity
++ + –
Telomeres +++ ++ +
Cytotoxicity – + ++
Cytokine secretion 
(TNF-α, IFN-γ)
– + ++
Signaling pathways
TCR signaling + ++ +/−
IL-2 signaling + ++ +/−
Pi3K–AKT–mTOR 
signaling
+ ++ +/−
p38MAPK 
activation
– – +
KLRG1, killer cell lectin-like receptor G1; NKR, natural killer receptor; KIR, killer cell 
immunoglobulin-like receptor; NKG2, natural killer receptor G2, TNF-α, tumor necrosis 
factor alpha; IFN-γ, interferon gamma; PI3K, phosphatidylinositol-3 kinase; mTOR, 
mammalian target of rapamycin.
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similar observations in end-stage CD8+ T cells. Interestingly, 
as T  cells progressively differentiate, they concomitantly start 
expressing NK lineage receptors. Collectively, these observations 
suggest that, as CD8+ T cells terminally differentiate, they become 
less dependent on antigen-specific signals and more responsive to 
innate-like signals.
TCR HYPOReSPONSiveNeSS iN 
TeRMiNALLY DiFFeReNTiATeD T CeLLS
Conventionally, optimal activation of T cells requires the engage-
ment of the TCR and the second signal usually delivered by 
co-stimulatory receptors or cytokines. However, as previously 
mentioned, T cell senescence is associated not only with the loss 
of co-stimulatory receptors but also with impairment of TCR 
signaling (43, 44), leading to defects in classical T cell functions.
Changes in the composition of membrane lipids and lipid rafts 
have been described and linked to the age-related changes in TCR 
proximal signaling (45). More recently, Li and colleagues investi-
gated the molecular mechanisms accounting for the loss of TCR 
sensitivity with age and found a correlation with the decreased 
expression of miR-181a and increased activity of DUSP6, a phos-
phatase that negatively regulates proximal TCR signaling (46). 
We recently demonstrated that the accumulation of DNA damage 
in senescent CD4+ T cells leads to the activation of AMP kinase, 
which is implicated in the decreased expression of key elements 
of the proximal TCR machinery, leading to impaired proximal 
TCR signaling in these cells (39). It is evident from these studies 
that aging is associated with a decrease in TCR responsiveness. 
Interestingly, recent studies have linked the acquisition of innate-
like effector functions by memory CD8 T cells with defective TCR 
signaling (47–49).
TCR-iNDePeNDeNT ACTivATiON OF 
αβCD8+ T CeLLS
Accumulating evidence indicates that memory CD8+ T cells may 
be activated in a TCR-independent manner through a process 
called bystander activation. This occurs in the absence of the 
cognate antigen, through the action of inflammatory cytokines, 
such as type I interferons (50, 51), IL-15 (52), IL-12 (53), IL-18, 
or a combination of these (5, 7, 54).
In addition to inflammatory cytokines, the acquisition of 
stimulatory innate immune receptors has been implicated 
in antigen-independent activation of CD8+ T cells. Among 
them, C-type lectin activating receptors, such as NKG2D and 
NKG2C, which recognize self-ligands related to the MHC-I 
have been shown to play crucial role in the mediation of 
innate-like responses by CD8+ T cells (6, 55). NKG2D is a 
classical example of a NK cell receptor that is highly expressed 
on αβCD8+ T cells and subsets of γδ T cells (56, 57). While the 
general consensus is that NKG2D engagement serves as a co-
stimulatory receptor in CD8+ T cells, amplifying TCR signals 
in virus-specific responses (58) as well as antitumor immunity 
(59, 60), other studies have provided compelling evidence that 
CD8+ T cells may respond to NKG2D ligation alone, without 
TCR engagement, provided that cells are stimulated with 
cytokines, such as IL-15 or high doses of IL-2 (6, 49, 61, 62). 
Such TCR-independent, NKG2D-dependent mechanism of 
activation of CD8+ T cells has been shown important for host 
defense against infections (49) and tumor surveillance (63) but 
has also been implicated in the pathogenesis of inflammatory 
and autoimmune reactions (6).
Collectively, these findings challenge the classic paradigm that 
TCR engagement by the cognate antigen is necessary for the acti-
vation of T cells and support the role of innate-like receptors in the 
regulation of T cell effector functions. Overall, such observations 
may shed light on the question of how senescent T cells maintain 
potent effector functions, despite the TCR hyporesponsiveness.
eXPANSiON OF αβCD8+ T CeLLS 
eXPReSSiNG NK CeLL ReCePTORS 
wiTH AGiNG
Studies in human centenarians have shown an increased propor-
tion of T cells expressing NK cell receptors (NKRs), whereas 
these cells represent a minor population of circulating lympho-
cytes in newborns and young healthy individuals (64, 65). The 
frequency of NKR-expressing T cells not only increases with age 
but also in conditions associated with chronic immune activation 
(66–68). Among the most commonly observed NKR on T cells 
are activating and inhibitory receptors, such as CD16, CD56, 
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CD57, NKp30, KLRG1, and CD94, members of the NK receptor 
G2 (NKG2), and killer-cell immunoglobulin-like receptor (KIR) 
families (10, 66–69).
Phenotypic analysis of NKR-expressing T cells revealed 
that the majority of these cells are highly differentiated effector 
memory CD8+ T cells, lacking CD28 expression and exhibiting 
other features of senescence (62, 69–71). Importantly, it has been 
demonstrated that these cells derive from conventional αβCD8+ 
T cells (71), express an oligoclonal αβTCR, and do not express 
the semi-invariant TCR Vα24/Vβ11 chains, excluding that they 
represent an expansion of the classical iNKT cells (17).
A recent study using single-cell mass cytometry to analyze 
the expression of NKR across the human immune system 
found, as expected, an increased expression of NK cell markers 
on CD8+ T cells, more evident in individuals with high levels 
of CD57, indicative of a terminally differentiated immune 
system (10). As the immune system matures, the diversity of 
the NKR repertoire increases on both NK and CD8+ T cells; 
however, the difference in magnitude for the gain of activating 
receptors appears to be much higher in CD8+ T than in NK 
cells. Hierarchical clustering based on NKR expression patterns 
unexpectedly clustered CD8+ T cells closer to mature NK cells 
than to CD4+ T cells.
Although the expansion of NKR-expressing T cells is mostly 
evident in the CD8+ T cell compartment, the expression of 
NK cell markers has also been found on human CD4+ T cells. 
For instance, our group and others have identified a subset of 
highly differentiated CD4+ T cells expressing NKG2D as well as 
cytotoxic granules, expanded in aging (35, 72) and autoimmune 
diseases (73, 74).
What triggers the expression of NKRs on T cells with aging is 
not yet clearly defined. TCR engagement and cytokine stimula-
tion have been shown to induce the expression of NKRs on 
T cells both in vitro and in vivo (75, 76). In addition, studies in 
transplant recipients have demonstrated a striking upregulation 
of NKR in virus-specific CD8+ T cells after CMV reactivation 
(77), suggesting that chronic antigenic stimulation may drive the 
expansion of NKR-expressing T cells. Likewise, the upregulation 
of inhibitory NKRs, such as NKG2A and KLRG1, has been linked 
to clonal expansion after antigenic exposure and development of 
replicative senescence of T cells (20, 34, 78, 79).
RePROGRAMiNG OF SeNeSCeNT 
αβCD8+ T CeLLS iNTO iNNATe-LiKe 
T CeLLS
The biological significance of NKR acquisition on CD8+ T cells 
during aging is not yet fully understood. It remains unclear 
whether the expansion of NKR-expressing T cells with age is a 
stochastic effect associated with chronic antigenic stimulation or 
whether it represents a predetermined program to allow these 
cells to respond rapidly in an innate-like fashion.
Functional studies performed with human CD8+ T cells that 
were activated and expanded ex vivo in the presence of cytokines 
or after TCR cross-linking, revealed that the acquisition of an 
NK cell phenotype was generally associated with the acquisition 
of functional features characteristic of NK cells (75). Of particu-
lar note, these cytokine-induced killer (CIK) cells develop the 
capacity to mediate MHC-unrestricted killing of target cells, in 
particular tumor cells, identifying them as potential tools in can-
cer therapy (80). Such activity does not require prior antigenic 
exposure but involves the engagement of stimulatory NKR and 
prior stimulation with inflammatory cytokines. Interestingly, 
these cells display a duality of function, as they are able to 
mediate both TCR-independent and antigen-specific immune 
responses (81).
Gene-expression studies have greatly contributed to dissect-
ing the transcriptional changes occurring in aged T cells and 
shed light on the significance of NKR acquisition [reviewed in 
Ref.  (82)]. Fann and colleagues originally compared the gene-
expression profiles of human CD28null and CD28+ memory CD8+ 
T cells and found significant changes in the CD28null compart-
ment, such as (1) decreased expression of co-stimulatory recep-
tors, (2) acquired expression of NKRs (the majority of which 
have stimulatory activity), (3) upregulation of genes involved in 
cytotoxicity (in particular genes involved in the granule exocy-
tosis pathway, perforin and granzymes, and in the Fas ligand/Fas 
pathway), (4) elevated expression of chemokines and cytokine 
receptors, and (5) differentially expressed signaling molecules 
and transcription factors (83). Subsequent studies comparing 
gene-expression profiles of CD8+ T cells between young and old 
donors have found similar changes, particularly in relation to 
enhanced expression of genes in the NK cell cluster (84, 85). 
Of particular note, Cao et  al. described additional changes at 
the level of cell signaling pathways in aged CD8+ T cells, the 
most prominent involving an age-decreased expression of genes 
associated with TCR, IGF-1, and PI3K/AKT signaling pathways 
(85). Collectively, these studies point to a common transcrip-
tional signature in aged CD8+ T  cells that most likely reflect 
the acquisition of potent cytotoxic effector functions, largely 
independent of TCR signals.
It remains to be determined which transcriptional factors 
are the main regulators of this program. The differential expres-
sion of T-box transcription factors, T-bet and eomesodermin 
(Eomes) in aged T cells compared to the less differentiated coun-
terparts (83), suggests a role in the reprograming of senescent 
CD8+ T cells. However, several other transcriptional regulators 
have been implicated in the terminal differentiation of cytotoxic 
CD8+ T  cells, including the Foxo family of transcription fac-
tors [reviewed in Ref. (86), Blimp-1 (87, 88), ZEB2 (89), and 
promyelocytic leukemia zinc finger (PLZF) (90)]. Interestingly, 
some of these factors have been also implicated in the tran-
scriptional control of NK and NKT cell differentiation (91, 92), 
and PLZF has been proposed as the key determinant factor for 
the development of innate T cells (92, 93). More importantly, 
overexpression of PLZF in conventional T cells was sufficient 
for the acquisition of innate-like phenotype and functions 
(90). Many questions remain in regard to the transcriptional 
program underlying T cell senescence. Importantly, it remains 
to be determined which factors control the peripheral modula-
tion of TCR signaling and whether there is a mechanistic link 
between the acquisition of NKRs and the modulation of the 
TCR machinery.
FiGURe 1 | Reprograming of CD8+ T cells into NK-like T cells with aging. Progression toward terminal differentiation or senescence is associated with 
phenotypic, functional, and transcriptional changes that lead to the expansion of NK-like CD8+ T cells.
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Collectively, these observations indicate that the acquisition 
of receptors that are normally found on NK cells may be part of a 
general reprograming of CD8+ T cells with maturation (Figure 1). 
Not only these cells acquire phenotypic markers of NK cells but 
also they acquire innate-like cytolytic functions, suggesting that a 
coordinated transcriptional program endows these cells with the 
machinery to respond to innate stimuli, without the requirement 
for TCR activation.
SiMiLARiTieS AND DiFFeReNCeS wiTH 
iNNATe-LiKe T CeLLS
Innate-like T cells are phenotypically characterized by the co-
expression of a TCR with conventional NK cell lineage markers. 
NKT cells are the prototypical example of innate T lymphocytes. 
The term NKT cell is sometimes misused to refer to other subsets 
of conventional αβT cells that express NKRs, although there 
are fundamental differences between them. Classical NKT cells 
express an invariant TCR (Va24Ja18) that recognize glycolipids 
presented by the monomorphic CD1d molecule, and they 
account for 0.1–1% of T cells in human peripheral blood (94), 
whereas conventional αβT cells expressing NKR exhibit a diverse 
TCR repertoire and their frequency in peripheral blood is much 
higher, increasing with age and chronic inflammatory diseases 
(68). In striking contrast, aging is associated with decreased 
frequency and function of iNKT cells (95, 96).
Recently, it has been proposed that the suppression of TCR 
signaling is critical for the development of innate-like T cells. 
An elegant study done by Hayday and colleagues in mice models 
has brought some insights into how innate T cells downmodu-
late the TCR signaling machinery to allow an innate mode of 
activation in peripheral tissues, independent of the TCR (97). 
The authors demonstrated that this mechanism of TCR tuning 
after development in the thymus, concomitant with acquisition 
of responsiveness to innate signals is a feature shared by diverse 
subsets of innate-like T cells, including CD27− γδT cells, mouse 
dendritic epidermal T cells (DETCs), and intestinal epidermal 
TCRαβ+ and γδ+ T cells. Although they could not find a 
similar mechanism to occur in iNKT cells, another study has 
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demonstrated the acquisition of transient innate responsiveness 
by human iNKT cells via histone modifications induced by weak 
TCR stimulation (98).
Functionally, it has been demonstrated that innate-like lym-
phocytes are able to respond to TCR ligation as well as to innate 
signals alone, in particular to NKG2D ligation and to inflamma-
tory cytokines (99–101). In humans, conventional αβCD8+ cells 
in celiac disease have been shown to respond to NKG2D ligands 
and pathological levels of IL-15, independently of TCR ligation 
(6). It remains to be determined if TCR signaling is suppressed in 
these cells, suggesting a common signature with other innate-like 
T cells.
Collectively, the observations that terminally differentiated 
CD8+ T cells co-express NKR and TCR have decreased TCR 
responsiveness and yet are able to respond rapidly to stimula-
tion, without the requirement for cognate antigen supports 
the hypothesis that human senescent αβCD8+ T cells exhibit 
phenotypic and functional features that resemble other innate-
like T cells. Nevertheless, the origin and development of human 
senescent αβCD8+ T cells is distinct from that of classical innate 
T cells. While innate T cells are developmentally pre-programed 
in the thymus (12), αβCD8+ T cells with innate-like features arise 
in the periphery, most likely as a result of a general reprograming 
driven by external environmental cues. The different origin may 
explain why aging is associated with a decreased frequency of 
innate T cells such as NKT cells, as a result of thymic involution, 
whereas the number of conventional αβT cells expressing NKR 
increases in the elderly, most likely a result of the homeostatic 
redistribution of T cells to compensate for the decrease in the 
output of T cells from the thymus with age.
PHYSiOLOGiCAL ROLe OF iNNATe-LiKe 
αβCD8+ T CeLLS
The capacity to mediate dual innate and adaptive immune func-
tions place senescent αβCD8+ T cells alongside other innate-like 
cells in the frontline of defense against pathogens and tumors. 
The acquisition of innate sensors specialized in the recognition 
of “danger” signals allows these cells to switch to a rapid and effi-
cient mode of action in potentially harmful situations. Given the 
increased burden of tumors and infections with age, the contribu-
tion of such innate-like CD8+ T cells may be crucial. The capacity 
to mediate MHC-unrestricted killing against a broad array of 
tumor targets has been demonstrated in vitro and in vivo with 
CIK cells putting these cells as attractive candidates for immuno-
therapy in solid organ and hematopoietic cancer treatment (102). 
Interestingly, despite showing a decreased TCR responsiveness, 
studies indicate that these cells still retain the capacity to elicit 
specific TCR-dependent immune responses (81).
Nevertheless, the reversal of antigen-specific CD8+ T cells 
to an innate mode of function is not without consequence. The 
peripheral requirement for TCR engagement for T cell activation 
is an important control mechanism to prevent autoreactivity. In 
conditions associated with chronic activation and inflamma-
tion, the balance between activating and inhibitory signals may 
favor the onset of autoimmune reactions. Recent reports have 
demonstrated a role of NKG2D in CD8+ T cell activation in 
inflammatory states and other stress conditions where NKG2D 
ligands are induced in normal tissues, such as celiac disease (6), 
type I diabetes (103), and transplantation (104, 105).
CONCLUDiNG ReMARKS
In this review, we summarize evidence indicating that chrono-
logical aging is associated with accumulation of cells combining 
features of both the innate and adaptive arms of the immune 
system, most likely to compensate for functional defects of 
conventional NK and CD8+ T cells with age. We propose that 
senescent CD8+ T cells should not be seen as a dysfunctional 
population but instead a functionally distinct subset, which uses 
recently acquired NK cell machinery to maintain rapid effector 
functions throughout life. Contrary to the classic paradigm that 
peripheral TCR ligation is essential for T cell activation, this subset 
of highly differentiated T cells has impaired TCR responsiveness 
and may be non-specifically activated by inflammatory cytokines 
or after ligation of innate receptors. The switch to an innate mode 
of function may shed light on the mechanisms that allow highly 
differentiated CD8+ T cells to maintain they polyfunctionality, 
despite the loss of TCR signalosome.
Our understanding of the physiological significance of the 
expression of NKRs on T cells is still incomplete, and the iden-
tification of the molecular mechanisms and the transcriptional 
regulators underpinning the development of innate features 
in T cells is essential. Most importantly, it will be important to 
understand how the intersection between innate and adaptive 
immune features may be manipulated to enhance immune func-
tion and to use this information to develop new approaches to 
improve immunity in the elderly.
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